Document is current
Any future updates will be listed below
-
Authors
Díaz-Gavela, Ana A. https://orcid.org/0000-0002-8453-5971
del Cerro, E. https://orcid.org/0000-0003-0942-0434
Sanchez-Garcia, S. https://orcid.org/0000-0002-1924-3067
Andreu-Vázquez, C. https://orcid.org/0000-0002-7558-4325
Thuissard-Vasallo, I. J. https://orcid.org/0000-0002-6990-0619
Sanz-Rosa, D. https://orcid.org/0000-0003-2177-5895
Pena-Huertas, M. https://orcid.org/0000-0002-3102-4481
Ruiz-Morales, C. https://orcid.org/0000-0003-1233-3278
Guerrero-Gomez, L. L. https://orcid.org/0000-0002-1275-9781
Duque-Santana, V. https://orcid.org/0000-0001-7505-8176
Hernandez-Cortés, G. https://orcid.org/0000-0001-9162-3649
Gonzalez-Cortijo, L. https://orcid.org/0000-0003-2082-670X
Counago, F. https://orcid.org/0000-0001-7233-0234
- License Information
-
More Information
Article History
Received: 23 October 2024
Accepted: 26 February 2025
First Online: 27 March 2025
Declarations
:
: The research protocol for this descriptive, retrospective, longitudinal study was approved by the Jiménez Díaz Foundation’s Ethics and Research Committee with Medicines (Madrid, Spain) on March 5, 2020. Given the retrospective nature of the study, and the possibility that some patients included in the study may no longer attend the hospital or may have passed away, a waiver for individualized informed consent was requested, which was granted. The investigators strictly adhered to the approved protocol established by the ethical research committee, ensuring accurate completion of data collection forms. The study was conducted in accordance with the recommendations outlined in the Declaration of Helsinki, as revised in successive World Medical Assemblies, and in compliance with Good Clinical Practice Guidelines.
: Not applicable.
: The authors declare no competing interests.
